Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1327775.RAGOCbStkae7Qr-Y-HuUy_fm_If3vnV0FyTAQHmktIfSw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1327775.RAGOCbStkae7Qr-Y-HuUy_fm_If3vnV0FyTAQHmktIfSw130_assertion type Assertion NP1327775.RAGOCbStkae7Qr-Y-HuUy_fm_If3vnV0FyTAQHmktIfSw130_head.
- NP1327775.RAGOCbStkae7Qr-Y-HuUy_fm_If3vnV0FyTAQHmktIfSw130_assertion description "[Although the rate of p53 mutations in pancreatic tumours is of the same order as in other adenocarcinomas (> or = 50%), an antibody response was found in only 5/78 (6.4%) sera from patients with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327775.RAGOCbStkae7Qr-Y-HuUy_fm_If3vnV0FyTAQHmktIfSw130_provenance.
- NP1327775.RAGOCbStkae7Qr-Y-HuUy_fm_If3vnV0FyTAQHmktIfSw130_assertion evidence source_evidence_literature NP1327775.RAGOCbStkae7Qr-Y-HuUy_fm_If3vnV0FyTAQHmktIfSw130_provenance.
- NP1327775.RAGOCbStkae7Qr-Y-HuUy_fm_If3vnV0FyTAQHmktIfSw130_assertion SIO_000772 7947080 NP1327775.RAGOCbStkae7Qr-Y-HuUy_fm_If3vnV0FyTAQHmktIfSw130_provenance.
- NP1327775.RAGOCbStkae7Qr-Y-HuUy_fm_If3vnV0FyTAQHmktIfSw130_assertion wasDerivedFrom befree-2016 NP1327775.RAGOCbStkae7Qr-Y-HuUy_fm_If3vnV0FyTAQHmktIfSw130_provenance.
- NP1327775.RAGOCbStkae7Qr-Y-HuUy_fm_If3vnV0FyTAQHmktIfSw130_assertion wasGeneratedBy ECO_0000203 NP1327775.RAGOCbStkae7Qr-Y-HuUy_fm_If3vnV0FyTAQHmktIfSw130_provenance.